AstraZeneca-linked ovarian cancer trial posts results; myeloma follow-up study status reconfirmedNov 13Weekly roundup, 10 itemsAstraZenecaAZD0120Updated
Fred Hutchinson posts Phase II acalabrutinib results; AstraZeneca's AZD0780 LDL-C trial completesOct 16Weekly roundup, 11 itemsacalabrutinibAstraZenecaUpdated
AstraZeneca completes Phase 1 laroprovstat/ezetimibe bioavailability study in healthy adultsOct 2Weekly roundup, 6 itemsacalabrutinibanifrolumab-fnia